Epidemiology of purulent bacterial meningitis in the period of pneumococcal and haemophilus vaccination in the Russian Federation


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To determine the current epidemiological features of the generalized form of meningococcal infection, pneumococcal meningitis, and Haemophilus meningitis during routine Haemophilus and pneumococcal vaccination and meningococcal vaccination, as epidemically indicated. Materials and methods. 170 reporting forms from 85 regions of the Russian Federation, which describe 2219 cases of purulent bacterial meningitis, were analyzed. Biomaterials from 370 patients were examined. Results. There was a vaccination-induced decrease in the incidence rates of pneumococcal and Haemophilus meningitis in children under 5 years of age. Conclusion. It is necessary to increase pneumococcal vaccination coverage in children and adults older than 60 years; to expand indications for vaccination against Haemophilus influenza, so that the vaccinated should include all children above 3 months of age, and not just risk-group children; to consider prospects for the national immunization calendar to include vaccination against meningococcal infection, by taking into account its heavy burden and poor prognosis due to that there may be a regular epidemic rise in morbidity rates.

全文:

受限制的访问

作者简介

I. Koroleva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: irina-korol@yandex.ru
MD, Head, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis 3a, Novogireevskaya St., Moscow 111123, Russia Теlephone: +7(495) 672-11-28

M. Koroleva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: korolevamaria389@mail.ru
Cand. Med. Sci., Senior Researcher, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis Moscow, Russi

A. Melnikova

Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: Melnikova_AA@gsen.ru
Cand. Med. Sci., Deputy Head, Department of Epidemiological Surveillance Moscow, Russi

参考

  1. Скрипченко Н.В., Вильниц А.А. (ред.). Менингококковая инфекция у детей. Руководство для врачей. СПб: Тактик-Студио, 2015. 840 с.
  2. Swartz M.N. Bacterial meningitis - a view of the past 90 year. N. Engl. J. Med. 2012; 351(18): 1826-8.
  3. Bottomley M.J., Serruto D., Safadi M.A.P., Klugman K.P. Future challenges in the elimination of bacterial meningitis. Vaccine 2012; (Suppl. 2): B78-86.
  4. Dery M.A. Changing epidemiology of bacterial meningitis. Curr. Infect. Dis. Rep. 2007; (9): 301-7.
  5. Wenger J.D., Hightower A.W., Facklam R.R. et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J. Infect. Dis. 1990; 162: 1316-23.
  6. Schuchat A., Robinson K., Wenger J.D. et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 1997; 337: 970-6.
  7. Tan L.K., Carlone G.M., Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 2010; 362(16): 1511-20.
  8. Королева И.С., Королева М.А., Белошицкий Г.В. Современная эпидемическая ситуация по менинго-кокковой инфекции в Российской Федерации и возможности вакцинопрофилактики. Медицинский алфавит. Эпидемиология и гигиена 2016; (1): 15-7.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2017
##common.cookie##